Voting Rights and Shares Capital of the Company

Rhea-AI Summary

Nanobiotix (Euronext Paris / Nasdaq: NBTX) reported its share capital and voting rights as of June 30, 2026, in accordance with French regulations (articles L.233-8 II of the French Commercial Code and 223-16 of the AMF General Regulation).

According to Nanobiotix, the company had 50,825,682 shares outstanding, corresponding to 54,486,890 theoretical (gross) voting rights and 54,464,772 exercisable (net) voting rights. The theoretical voting rights figure includes shares with suspended rights, while the exercisable voting rights exclude shares held in treasury.

Market Context

The prior voting-rights disclosure, news_id 1067595, was followed by a 1.18% move. This filing adds ...

Analysis

The prior voting-rights disclosure, news_id 1067595, was followed by a 1.18% move. This filing adds another capital-structure data point; future changes in shares and voting rights remain the relevant comparison.

Key Figures

Reporting date: June 30, 2026 Shares outstanding: 50,825,682 shares Theoretical voting rights: 54,486,890 voting rights +4 more

7 metrics

Reporting date June 30, 2026 Share capital and voting rights disclosure

Shares outstanding 50,825,682 shares As of June 30, 2026

Theoretical voting rights 54,486,890 voting rights As of June 30, 2026

Exercisable voting rights 54,464,772 voting rights As of June 30, 2026

Patent families More than 30 patent families Company description

Nanotechnology platforms Three nanotechnology platforms Company description

Incorporation year 2003 Company history

Historical Context

5 past events · Latest: Jun 05 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jun 05	Voting rights update	Neutral	+1.2%	Reported May share capital and theoretical and exercisable voting rights.
Jun 02	Operational update	Positive	-4.2%	Reported clinical progress, financing completion, and cash supporting operations into 2029.
Jun 02	Index inclusion	Positive	-3.3%	Joined the Euronext Tech Leaders segment and Euronext Tech Leaders Index.
May 26	Global offering	Negative	-0.7%	Closed a global offering raising approximately $100 million in gross proceeds.
May 22	Offering upsizing	Negative	-0.5%	Underwriters fully exercised the over-allotment option, increasing offering proceeds.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent history showed divergence on positive corporate updates, while offering announcements produced smaller negative reactions.

Key Terms

isin code, theoretical voting rights, exercisable voting rights

3 terms

isin code financial

"ISIN code: FR0011341205"

An ISIN code is a unique identifier for a specific financial asset, like a stock or bond, similar to a product's barcode. It helps investors, traders, and banks quickly and accurately find and track that asset across different markets worldwide. This makes buying, selling, and managing investments more organized and reliable.

theoretical voting rights regulatory

"Total voting rights, theoretical1"

Theoretical voting rights are the share of control an investor would have if all possible sources of additional shares—such as stock options, warrants and convertible bonds—were turned into ordinary shares. Investors care because this “what-if” number shows potential dilution of current owners and the maximum voting power others could gain, helping assess control risk and how future actions might change company decisions, like a snapshot of ownership if every coupon were cashed in.

exercisable voting rights regulatory

"Total voting rights,exercisable2"

Exercisable voting rights are the actual, usable votes attached to a security or position that allow the holder to influence company decisions at shareholder meetings—for example electing the board or approving mergers. They matter to investors because the number of votes someone can cast determines who controls the company and its strategy, similar to having usable tickets at a town meeting rather than placeholders, and can affect share value, takeover risk and how much influence minority holders have.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PARIS, July 30, 2026 (GLOBE NEWSWIRE) -- In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)

Paris, France, July 30, 2026
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website: www.nanobiotix.com

Date	Number of Shares Outstanding	Total number of voting rights
		Total voting rights, theoretical1	Total voting rights, exercisable2
June 30, 2026	50,825,682	54,486,890	54,464,772

***

About NANOBIOTIX

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.

Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has a subsidiary in Cambridge, Massachusetts (United States).

Nanobiotix is the owner of more than 30 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.

For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.

Contacts

Nanobiotix
Communications Department Brandon Owens VP, Communications +1 (617) 852-4835 contact@nanobiotix.com	Investor Relations Department Joanne Choi VP, Investor Relations (US) +1 (713) 609-3150 Ricky Bhajun Director, Investor Relations (EU) investors@nanobiotix.com
Media Relations
France – HARDY Caroline Hardy +33 06 70 33 49 50 carolinehardy@outlook.fr	Global – uncapped Becky Lauer +1 (646) 286-0057 uncappednanobiotix@uncappedcommunications.com

 

¹ The total number of theoretical (or “gross”) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.

² The total number of exercisable at a shareholders’ meeting (or “net”) voting rights is calculated without taking into account shares for which voting rights have been suspended as shares held in treasury by the Company. It is released in order to ensure that the public is properly informed.

Attachments

• 2026-07-30 -- NBTX -- Voting Rights & Shares Capital -- FINAL

FAQ

How many shares outstanding does Nanobiotix (NBTX) report as of June 30, 2026?

Nanobiotix reports 50,825,682 shares outstanding as of June 30, 2026. According to Nanobiotix, this figure is the basis for calculating both theoretical and exercisable voting rights disclosed under French market transparency rules.

What are the total voting rights for Nanobiotix (NBTX) as of June 30, 2026?

Nanobiotix reports 54,486,890 theoretical voting rights and 54,464,772 exercisable voting rights as of June 30, 2026. According to Nanobiotix, theoretical rights include suspended votes, while exercisable rights exclude treasury shares with suspended voting rights.

What is the difference between theoretical and exercisable voting rights for Nanobiotix (NBTX)?

Theoretical voting rights include all shares with attached rights, even if suspended. According to Nanobiotix, exercisable voting rights exclude shares with suspended rights, such as treasury shares, and represent votes that can actually be cast at shareholder meetings.

Why does Nanobiotix (NBTX) publish voting rights and share capital information?

Nanobiotix publishes voting rights and share capital data to comply with French transparency rules. According to Nanobiotix, the figures are used for threshold crossing calculations and to keep the market properly informed about potential shareholder voting power.

On which markets is Nanobiotix (NBTX) listed and what is its ISIN code?

Nanobiotix is listed on Euronext Paris and the Nasdaq Global Select Market. According to Nanobiotix, its ISIN code is FR0011341205, with trading symbols NBTX, NANO:FP on Bloomberg, and NANO.PA on Reuters.

How are Nanobiotix (NBTX) voting rights used for threshold crossing notifications?

Threshold crossings are calculated using the theoretical voting rights figure. According to Nanobiotix, this gross number counts all shares with attached voting rights, including those temporarily suspended, as required by AMF Article 223-11.